BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29408703)

  • 1. Structural characterization of 14-3-3ζ in complex with the human Son of sevenless homolog 1 (SOS1).
    Ballone A; Centorrino F; Wolter M; Ottmann C
    J Struct Biol; 2018 Jun; 202(3):210-215. PubMed ID: 29408703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein X-ray crystallography of the 14-3-3ζ/SOS1 complex.
    Ballone A; Centorrino F; Wolter M; Ottmann C
    Data Brief; 2018 Aug; 19():1683-1687. PubMed ID: 30229043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOS1-inspired hydrocarbon-stapled peptide as a pan-Ras inhibitor.
    Li A; Li X; Zou J; Zhuo X; Chen S; Chai X; Gai C; Xu W; Zhao Q; Zou Y
    Bioorg Chem; 2023 Jun; 135():106500. PubMed ID: 37003134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1.
    Howes JE; Akan DT; Burns MC; Rossanese OW; Waterson AG; Fesik SW
    Mol Cancer Ther; 2018 May; 17(5):1051-1060. PubMed ID: 29440291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways.
    Tumurkhuu M; Saitoh M; Takita J; Mizuno Y; Mizuguchi M
    J Recept Signal Transduct Res; 2013 Apr; 33(2):124-8. PubMed ID: 23528009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange.
    Burns MC; Sun Q; Daniels RN; Camper D; Kennedy JP; Phan J; Olejniczak ET; Lee T; Waterson AG; Rossanese OW; Fesik SW
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3401-6. PubMed ID: 24550516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation.
    Saha M; Carriere A; Cheerathodi M; Zhang X; Lavoie G; Rush J; Roux PP; Ballif BA
    Biochem J; 2012 Oct; 447(1):159-66. PubMed ID: 22827337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature.
    Thompson SK; Buckl A; Dossetter AG; Griffen E; Gill A
    Expert Opin Ther Pat; 2021 Dec; 31(12):1189-1204. PubMed ID: 34253125
    [No Abstract]   [Full Text] [Related]  

  • 9. High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling.
    Burns MC; Howes JE; Sun Q; Little AJ; Camper DV; Abbott JR; Phan J; Lee T; Waterson AG; Rossanese OW; Fesik SW
    Anal Biochem; 2018 May; 548():44-52. PubMed ID: 29444450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction.
    Hillig RC; Sautier B; Schroeder J; Moosmayer D; Hilpmann A; Stegmann CM; Werbeck ND; Briem H; Boemer U; Weiske J; Badock V; Mastouri J; Petersen K; Siemeister G; Kahmann JD; Wegener D; Böhnke N; Eis K; Graham K; Wortmann L; von Nussbaum F; Bader B
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2551-2560. PubMed ID: 30683722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the Ras activator Son of Sevenless 1 by environmental pollutants mediates their effects on cellular proliferation.
    Pierre S; Bats AS; Chevallier A; Bui LC; Ambolet-Camoit A; Garlatti M; Aggerbeck M; Barouki R; Coumoul X
    Biochem Pharmacol; 2011 Jan; 81(2):304-13. PubMed ID: 20950586
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cowan JR; Salyer L; Wright NT; Kinnamon DD; Amaya P; Jordan E; Bamshad MJ; Nickerson DA; Hershberger RE
    Circ Genom Precis Med; 2020 Aug; 13(4):e002892. PubMed ID: 32603605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical Characterization of Essential Phosphorylation at the Flexible C-Terminal Region of C-Raf with 14-3-3ζ Protein.
    Ghosh A; Ratha BN; Gayen N; Mroue KH; Kar RK; Mandal AK; Bhunia A
    PLoS One; 2015; 10(8):e0135976. PubMed ID: 26295714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling.
    Luo G; Wang B; Hou Q; Wu X
    J Med Chem; 2023 Apr; 66(7):4324-4341. PubMed ID: 36987571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.
    Leshchiner ES; Parkhitko A; Bird GH; Luccarelli J; Bellairs JA; Escudero S; Opoku-Nsiah K; Godes M; Perrimon N; Walensky LD
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1761-6. PubMed ID: 25624485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.
    Evelyn CR; Duan X; Biesiada J; Seibel WL; Meller J; Zheng Y
    Chem Biol; 2014 Dec; 21(12):1618-28. PubMed ID: 25455859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOS1 over-expression in genital skin fibroblasts from hirsute women: a putative role of the SOS1/RAS pathway in the pathogenesis of hirsutism.
    Minella D; Wannenes F; Biancolella M; Amati F; Testa B; Nardone A; Bueno S; Fabbri A; Lauro D; Novelli G; Moretti C
    J Biol Regul Homeost Agents; 2011; 25(4):615-26. PubMed ID: 22217993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding SOS (Son of Sevenless).
    Pierre S; Bats AS; Coumoul X
    Biochem Pharmacol; 2011 Nov; 82(9):1049-56. PubMed ID: 21787760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on pathophysiological function of SOS1 protein].
    Hao PQ; Zhang XY; Guo H; Yang Y; An S; Liu Y; Guo XX; Xu TR; Hao Q
    Sheng Li Xue Bao; 2018 Oct; 70(5):565-570. PubMed ID: 30377696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting RAS oncogenesis with SOS1 inhibitors.
    Hillig RC; Bader B
    Adv Cancer Res; 2022; 153():169-203. PubMed ID: 35101230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.